Researchers identified a promising approach to slowing treatment-resistant prostate cancer by targeting two key cancer pathways at the same time. Prostate cancer is diagnosed in about one in eight men during their lifetime. Many survive the disease, but for some,…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.